Vercise is Designed to More Precisely Target Deep-Brain Stimulation

Boston Scientific's Vercise system for treating Parkinson's disease, tested in clinical trials led in part by a U of M neurologist, has received FDA approval.

Dr. Jerrold Vitek, head of the neurology department at the University of Minnesota and coordinating principal investigator for the Intrepid study, said the rounded shape of the Vercise's power generator may reduce surgical infections while the rechargeable battery is supposed to cut down on the number of generator-replacement surgeries.

Read the full story in the Star Tribune.